Evaluate the Relationship Between Class 1 Integrons and Drug Resistance Genes in Clinical Isolates of Pseudomonas aeruginosa. 2016

Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

BACKGROUND The prevalence of resistant Pseudomonas aeruginosa isolates is increasing and it is considered as one of the major public health concerns in the world. The association between integrons and drug resistance has been proven and evidences suggest that integrons are coding and responsible for dissemination of antibiotic resistance among P. aeruginosa isolates. OBJECTIVE This study is aimed to evaluate the relationship between class 1 integrons and drug resistance genes in clinical isolates of P. aeruginosa from burn patients. METHODS 100 isolates of P. aeruginosa were collected from burn patients hospitalized in the skin ward of Shahid Motahari hospital and susceptibility testing was performed by disk diffusion method (Kirby-Bauer). Then DNA was extracted and PCR technique was performed for the detection of class 1 integrons and drug resistance genes. Then data was analyzed using SPSS software. RESULTS The most effective antibiotic was polymyxin B with sensitivity 100%, and the most resistance was observed to the ciprofloxacin (93%) and amikacin (67%), respectively. The maximum and lowest frequencies of drug resistance genes belonged to the aac (6 ') - 1, VEB-1 with prevalence rate 93% and 10%, respectively. The statistical Chi-square test did not find any significant correlation between class 1 integrons and drug resistance genes (p˃ 0.05). CONCLUSIONS Although no significant correlation between class 1 integrons and drug resistance was observed, but the resistance rate to antibiotics tested among P. aeruginosa isolates was high. So, surveillance, optimization and strict consideration of antimicrobial use and control of infection are necessary.

UI MeSH Term Description Entries

Related Publications

Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
November 2011, International journal of antimicrobial agents,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
March 2012, The Southeast Asian journal of tropical medicine and public health,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
June 2005, FEMS immunology and medical microbiology,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
January 2020, Infection and drug resistance,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
April 2012, Antimicrobial agents and chemotherapy,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
November 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
March 2024, BMC microbiology,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
January 2009, Journal of clinical microbiology,
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
June 2020, Microbial drug resistance (Larchmont, N.Y.),
Seyed Mohammad Javad Hosseini, and Niloofar Shoaee Naeini, and Azad Khaledi, and Seyede Fatemeh Daymad, and Davoud Esmaeili
September 2010, Iranian journal of microbiology,
Copied contents to your clipboard!